BRUXISM SECONDARY TO CHRONIC ANTIDOPAMINERGIC DRUG EXPOSURE

Citation
F. Micheli et al., BRUXISM SECONDARY TO CHRONIC ANTIDOPAMINERGIC DRUG EXPOSURE, Clinical neuropharmacology, 16(4), 1993, pp. 315-323
Citations number
24
Categorie Soggetti
Pharmacology & Pharmacy",Neurosciences
Journal title
ISSN journal
03625664
Volume
16
Issue
4
Year of publication
1993
Pages
315 - 323
Database
ISI
SICI code
0362-5664(1993)16:4<315:BSTCAD>2.0.ZU;2-I
Abstract
Eight cases of diurnal bruxism (DB) secondary to long-term antidopamin ergic drug exposure are reported. Five exhibited a grinding pattern, o ne a clenching form, and two a mixed type. An odontological etiology w as absent throughout. EMG recordings disclosed two distinct patterns o f muscle activity, one with brief rhythmic, forceful contractions and the other featuring sustained prolonged contractions. Surface EMG and EEG monitoring during a 24-h period confirmed the absence of bruxism d uring sleep. Several drug trials failed to provide relief. Our finding s support DB as a focal tardive dystonia syndrome.